{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:25:42Z","timestamp":1762507542047,"version":"3.37.3"},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As the transgender community has become increasingly visible in public life, a greater awareness of this group's unique health needs and obstacles to optimal medical care has developed. Unfortunately, transgender youth face multiple barriers within the health care system, including access to equitable and gender\u2010affirming care. As dermatologists who care for children and adolescents, we must be aware of the challenges facing transgender youth and work to correct the disparities that exist for this vulnerable group. An initial step in supporting our transgender patients is to advocate for changes to the <jats:styled-content style=\"fixed-case\">iPLEDGE<\/jats:styled-content> system for prescribing isotretinoin (and other Risk Evaluation and Mitigation Strategy systems), specifically requesting a change to its gender\u2010binary categorization model that compromises an individual's right to self\u2010identify. By promoting a gender\u2010neutral patient categorization that is based instead upon reproductive potential, a simple change to the <jats:styled-content style=\"fixed-case\">iPLEDGE<\/jats:styled-content> program allows us to safely treat all of our patients requiring isotretinoin, while preserving our transgender patients\u2019 rights to self\u2010determination and self\u2010identification.<\/jats:p>","DOI":"10.1111\/pde.13694","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T07:54:21Z","timestamp":1539590061000},"page":"169-171","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prescribing isotretinoin for transgender youth: A pledge for more inclusive care"],"prefix":"10.1111","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7179-5168","authenticated-orcid":false,"given":"Markus D.","family":"Boos","sequence":"first","affiliation":[{"name":"Division of Dermatology Department of Pediatrics Seattle Children's Hospital University of Washington School of Medicine Seattle Washington USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Ginsberg","sequence":"additional","affiliation":[{"name":"Department of Dermatology Icahn School of Medicine at Mount Sinai New York City New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Klint","family":"Peebles","sequence":"additional","affiliation":[{"name":"Department of Dermatology School of Medicine and Public Health University of Wisconsin Madison Wisconsin USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2016.07.002"},{"volume-title":"The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding","year":"2011","key":"e_1_2_3_3_1"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1283"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60371-7"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2016.07.001"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2014.11.002"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.10.013"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12149"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.10.1303"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.004"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13448"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.0761"},{"key":"e_1_2_3_14_1","unstructured":"iPLEDGE program: patient introductory brochure.2016.https:\/\/www.ipledgeprogram.com\/iPledgeUI\/rems\/pdf\/resources\/The%20iPLEDGE%20Program%20Patient%20Introductory%20Brochure.pdf. Accessed June 10 2018."},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000540"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.5547"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.03.017"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.042"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.0736"},{"key":"e_1_2_3_20_1","unstructured":"American medical association gender identity inclusion and accountability in REMS D\u2010100.968.2017.https:\/\/policysearch.ama-assn.org\/policyfinder\/detail\/REMS?uri=%2FAMADoc%2Fdirectives.xml-D-100.968.xml. Accessed June 10 2018."},{"key":"e_1_2_3_21_1","unstructured":"American academy of dermatology position statement on isotretinoin. Updated February 17 2018.https:\/\/www.aad.org\/Forms\/Policies\/Uploads\/PS\/ps-isotretinoin.pdfAccessed June 10 2018."}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpde.13694","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.13694","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/pde.13694","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.13694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T12:13:39Z","timestamp":1694002419000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.13694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/pde.13694"],"URL":"https:\/\/doi.org\/10.1111\/pde.13694","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"type":"print","value":"0736-8046"},{"type":"electronic","value":"1525-1470"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"2018-10-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}